Allspring Global Investments’s Puma Biotechnology PBYI Stock Holding History

Allspring Global Investments’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Buy	17,945 +879	+5%	+$6.44K	﹤0.01%	1687
2026 Q1	$109K	Buy	+17,066	New	+$110K	﹤0.01%	1643
2024 Q4	–	Sell	-667	Closed	-$1.7K	–	2227
2024 Q3	$1.7K	Buy	+667	New	+$2.02K	﹤0.01%	2278
2022 Q2	–	Sell	-189,314	Closed	-$545K	–	2863
2022 Q1	$545K	Sell	189,314 -57,886	-23%	-$150K	﹤0.01%	2183
2021 Q4	$751K	Buy	+247,200	New	+$1.07M	﹤0.01%	2107

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's PBYI Position: Q2 2026 in Review

Allspring Global Investments increased its Puma Biotechnology (PBYI) stake by 5.2% in Q2 2026, buying an estimated $6.44K and bringing the position to 17,945 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

Allspring Global Investments first reported a position in PBYI in Q4 2021 and has held it in 5 quarters since. The position peaked at $751K in Q4 2021. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

Allspring Global Investments held 17,945 shares of Puma Biotechnology worth $143K as of Q2 2026.
Allspring Global Investments bought 879 Puma Biotechnology shares in Q2 2026, an estimated $6.44K.
Puma Biotechnology made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1687 holding.
Allspring Global Investments first reported a position in Puma Biotechnology in Q4 2021 and has held it in 5 quarters since.
Allspring Global Investments's Puma Biotechnology position peaked at $751K in Q4 2021.
160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.